Gráfico do Preço
GRÁFICO POR
Informações
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
- Indústrias
- Biotechnology
- Sector
- Cuidados de saúde
Identificador
- ISIN
- DE000A0V9BC4
- Rastreador primário
- 22U